by Roshan Yoganathan | Feb 18, 2014
. This past weekend I was watching the Superbowl, along with millions of North Americans,not to see the Seahawks beat down the Broncos, but for all the must-see million dollar commercials. The one commercial that stood out to me was the Geico commercial with the...
by Mark Curtis | Feb 11, 2014
. Welcome to your Regenerative Medicine Deal Review for the month of January! There was lots of flow in January, including yet another research collaboration from Cellular Dynamics International – this time with the Nestle Institute of Health Sciences to use the...
by Mark Curtis | Feb 4, 2014
. Welcome to your Update from the Clinic for the month of January! We start the year off with the German health authority approving Pluristem’s next generation GMP cell manufacturing facility. Neuralstem successfully, and safely, transplants NSI-556 cells directly...
by Lisa Willemse | Jan 10, 2014
> Earlier this week, we tweeted some articles published online at Scientific American that provide some perspectives on the complexity and high costs of drug discovery – so far, two have been published, here and here. The tweet elicited a thought-provoking...
by Mark Curtis | Jan 7, 2014
. Welcome to your Update from the Clinic for the month of December. Athersys and NeoStem both confirm completion of enrollment for phase 2 studies while bluebird bio announces the first patient transplanted in its phase 1/2 study of HGB-205 in patients with...
Comments